Watch the Latest Installment of Translational Science Lecture Series (TSLS) The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic.…
Read More
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Aaron S. Farberg MD FAAD, one of the co-authors of “Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists:…
Read More
Public health messaging misses the mark on Monkeypox and HIV A cross‑jurisdiction survey of publicly available Monkeypox and HIV materials from state, large metropolitan and select non‑metro U.S. health departments…
Read More
Ten Years, One Live Celebration: Join the conversation We were proud to celebrate a remarkable milestone at ODAC 2026, held January 16-19, 2026. It was a fitting place to honor…
Read More
In skin of color, halo phenomena can mask benign lesions; biopsy and dermoscopic‑pathologic correlation remain essential It’s time to dive into one of our January JDD case reports ! A…
Read More
Barrier boost for acne care: A new gel moisturizer soothes, strengthens and lifts quality of life We’re highlighting a December 2025 article that features one of JDD’s most sought-after topics:…
Read More
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Read More
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Read More
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…
Read More
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…
Read More
Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Read More
Case report: six weeks of gentian violet and trichloroacetic acid peel produced marked healing in dominant dystrophic epidermolysis bullosa with minimal discomfort The February 2026 JDD issue features a case…
Read More
